Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CAMOFI Master LDC is an investment fund that specializes in providing capital to small-cap and micro-cap companies, with a significant focus on the biotechnology, life sciences, and healthcare sectors. The fund frequently participates in private investment in public equity (PIPE) transactions and has been a notable investor in several early-stage biotech firms, including Advanced Cell Technology and OncoVista Innovative Therapies. Managed by Centaurus Capital LP, CAMOFI Master is often involved in structured financing deals involving convertible debentures and warrants. The entity is known for its active role in legal and financial proceedings related to its investment terms and shareholder rights within the biotech industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CAMOFI Master.